SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-18-013757
Filing Date
2018-12-12
Accepted
2018-12-12 16:57:44
Documents
1
Period of Report
2018-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3332
  Complete submission text file 0001179110-18-013757.txt   4887
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Quinn William P. (Reporting) CIK: 0001724190 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 181231367